Deborah Slipetz - Concepedia

Author

Deborah Slipetz

Merck Canada Inc. (Canada)

Also Known As

D. Slipetz, Deborah A. Slipetz, Deborah Slipetz

Publications

360

Citations

H-Index

Concepts

All Affiliations

Merck Canada Inc. (Canada)Merck & Co., Inc., Rahway, NJ, USA (United States)United States Military Academy

About

Deborah Slipetz is an author at Merck Canada Inc. (Canada) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	149
2	Biochemistry	3	3	95
3	Health Sciences	1	1	22
4	Natural Sciences	1	1	53
5	Cell Biology	1	1	22

Deborah Slipetz

Publications

360

Citations

H-Index

Page 1

	Year	Citations
Prostaglandin Receptor EP<sub>4</sub> Mediates the Bone Anabolic Effects of PGE<sub>2</sub> M. Machwate, Satoru Harada, Chih‐Tai Leu, Molecular Pharmacology	2001	167
Discovery and Synthesis of a Potent, Selective and Orally Bioavailable EP4 Receptor Agonist Robert N. Young, Xavier Billot, Yongxin Han, Heterocycles Peptide SciencePharmacotherapyPharmaceutical ChemistryTranslational PharmacologyMolecular Pharmacology	2004	53
Comparison between two classes of selective EP3 antagonists and their biological activities Michel Belley, Chi Chung Chan, Yves Gareau, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryFunctional SelectivityMedicineImmunologyMechanism Of Action	2006	32
Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor Fiona Elwood, David J. Witter, Jennifer Piesvaux, Journal of Pharmacology and Experimental Therapeutics	2017	32
Structure–activity relationship studies on ortho-substituted cinnamic acids, a new class of selective EP3 antagonists Michel Belley, Michel Gallant, Bruno Roy, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyPharmaceutical ChemistryBiochemistryMedicineOrganic Chemistry	2004	28
Prostaglandin Receptor EP4 Mediates the Bone Anabolic Effects of PGE2 M. Machwate, Satoru Harada, Chih‐Tai Leu, Molecular Pharmacology Prostaglandin Receptor Ep4SclerostinSignal TransductionBone Morphogenic ProteinG Protein-coupled Receptor	2001	22
Discovery of potent and selective DP1 receptor antagonists in the azaindole series Yves Leblanc, Patrick Roy, Claude Dufresne, Bioorganic & Medicinal Chemistry Letters Drug TargetAzaindole SeriesBiochemistryFunctional SelectivityMedicine	2009	14
Sequestration and phosphorylation of the prostaglandin E2 EP4 receptor: dependence on the C-terminal tail33Abbreviations: PGE2, prostaglandin E2, GRK, G-protein coupled receptor kinase; PKA, protein kinase A; PKC, protein kinase C; PCR, polymerase chain reaction; DMEM, Dulbecco’s modified Eagle’s medium; PAS, protein A Sepharose; ECL, electrochemiluminescence; BCA, 2-bicinchoninic acid; IR, immunoreactivity; HBSS, Hanks’ buffered salt solution; TBS, Tris-buffered saline; cAMP, cyclic AMP; PMA, phorbol 12-myristate 13 acetate; and β2-AR, β2-adrenergic receptor. Deborah Slipetz, Stephanie Buchanan, Cameron D. Mackereth, Biochemical Pharmacology	2001	12

Page 1